|
|
||||||||
Journal of Lipid Research, Vol 33, 569-577, Copyright © 1992 by Lipid Research, Inc.
ARTICLES |
RV Farese Jr, A Garg, VR Pierotti, GL Vega and SG Young
Gladstone Foundation Laboratories for Cardiovascular Research, University of California, San Francisco 94140-0608.
Familial hypobetalipoproteinemia, a syndrome associated with low plasma cholesterol levels, can be caused by apoB gene mutations. We identified a healthy 42-year-old man whose total plasma cholesterol level was 80 mg/dl. His plasma very low density lipoprotein (VLDL) contained a unique truncated apoB species, apoB-83, in addition to the normal B apolipoproteins, apoB-100 and apoB-48. Virtually no apoB-83 was detectable in his low density lipoprotein (LDL). From the subject's kindred, we identified nine other hypocholesterolemic subjects whose VLDL contained apoB-83. A tendency for cholelithiasis was noted in the apoB-83 heterozygotes, particularly in the older individuals. From the apparent size of apoB-83 on SDS-polyacrylamide gels and its reactivity with apoB-specific monoclonal antibodies, we estimated that it would contain approximately 3700-3800 amino acids. DNA sequencing of apoB genomic clones from two affected individuals revealed that apoB-83 was caused by a C----A transversion in exon 26 of the apoB gene (apoB cDNA nucleotide 11458). This mutation converts Ser-3750 (TCA) into a premature stop codon (TAA) and creates a unique MseI restriction endonuclease site. Thus, a single nucleotide transversion in the apoB gene results in a unique truncated apoB species, apoB-83, and the clinical syndrome of familial hypobetalipoproteinemia.
This article has been cited by other articles:
![]() |
S W Fouchier, R R Sankatsing, J Peter, S Castillo, M Pocovi, R Alonso, J J P Kastelein, and J C Defesche High frequency of APOB gene mutations causing familial hypobetalipoproteinaemia in patients of Dutch and Spanish descent J. Med. Genet., April 1, 2005; 42(4): e23 - e23. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schonfeld Familial hypobetalipoproteinemia: a review J. Lipid Res., May 1, 2003; 44(5): 878 - 883. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xiao, J. Elovson, and V. N. Schumaker Rat McA-RH7777 cells efficiently assemble rat apolipoprotein B-48 or larger fragments into VLDL but not human apolipoprotein B of any size J. Lipid Res., January 1, 2000; 41(1): 116 - 125. [Abstract] [Full Text] |
||||
![]() |
R. A. K. Srivastava, N. Srivastava, M. Averna, A. B. Cefalu, and G. Schonfeld Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene J. Lipid Res., May 1, 1999; 40(5): 901 - 912. [Abstract] [Full Text] |
||||
![]() |
M. M. Veniant, E. Kim, S. McCormick, J. Boren, L. B. Nielsen, M. Raabe, and S. G. Young Insights into Apolipoprotein B Biology from Transgenic and Gene-Targeted Mice J. Nutr., February 1, 1999; 129(2): 451 - 451. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim, P. Ambroziak, M. M. Veniant, R. L. Hamilton, and S. G. Young A Gene-targeted Mouse Model for Familial Hypobetalipoproteinemia. LOW LEVELS OF APOLIPOPROTEIN B mRNA IN ASSOCIATION WITH A NONSENSE MUTATION IN EXON 26 OF THE APOLIPOPROTEIN B GENE J. Biol. Chem., December 18, 1998; 273(51): 33977 - 33984. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ohashi, S. Ishibashi, M. Yamamoto, J.-i. Osuga, Y. Yazaki, S. Yukawa, and N. Yamada A Truncated Species of Apolipoprotein B (B-38.7) in a Patient With Homozygous Hypobetalipoproteinemia Associated With Diabetes Mellitus Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1330 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kim and S. G. Young Genetically modified mice for the study of apolipoprotein B J. Lipid Res., April 1, 1998; 39(4): 703 - 723. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Welty, J. Ordovas, E. J. Schaefer, P. W.F. Wilson, and S. G. Young Identification and Molecular Analysis of Two ApoB Gene Mutations Causing Low Plasma Cholesterol Levels Circulation, October 15, 1995; 92(8): 2036 - 2040. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |